Postoperative Admission in Critical Care Units Following Gynecologic Oncology Surgery: Outcomes Based on a Systematic Review and Authors' Recommendations.
Critical care unit
cytoreduction
gynecologic oncology
intensive care unit
surgical intensive care unit
Journal
In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809
Informations de publication
Date de publication:
Historique:
received:
02
05
2020
revised:
15
05
2020
accepted:
16
05
2020
entrez:
3
9
2020
pubmed:
3
9
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
The present study aimed to evaluate the predictors of admission to the Critical Care Units (CCUs) and factors predisposing to prolonged stay in CCUs after gynecological oncology surgery. Studies which addressed cases of women who underwent surgery for gynecological malignancies and required postoperative CCU admission were included. Seven studies with 3820 patients were included. Among them, 1680 required admission to CCU. Advanced age, higher Charlson Comorbidity Index (CCI) score, longer operative times, protracted blood loss and intestinal resection were associated with higher probability of CCU admission. Patients' age, operative times, blood loos and intestinal resection were significant predictors of prolonged stay to CCUs. Admission to CCU and length of stay following surgery for gynecologic malignancies is driven by specific patient characteristics as well as intraoperative values. Further studies are needed to validate high risk patients who will benefit from postoperative care to CCUs to ensure favorable postoperative outcomes and cost-effectiveness.
Sections du résumé
BACKGROUND/AIM
OBJECTIVE
The present study aimed to evaluate the predictors of admission to the Critical Care Units (CCUs) and factors predisposing to prolonged stay in CCUs after gynecological oncology surgery.
PATIENTS AND METHODS
METHODS
Studies which addressed cases of women who underwent surgery for gynecological malignancies and required postoperative CCU admission were included.
RESULTS
RESULTS
Seven studies with 3820 patients were included. Among them, 1680 required admission to CCU. Advanced age, higher Charlson Comorbidity Index (CCI) score, longer operative times, protracted blood loss and intestinal resection were associated with higher probability of CCU admission. Patients' age, operative times, blood loos and intestinal resection were significant predictors of prolonged stay to CCUs.
CONCLUSION
CONCLUSIONS
Admission to CCU and length of stay following surgery for gynecologic malignancies is driven by specific patient characteristics as well as intraoperative values. Further studies are needed to validate high risk patients who will benefit from postoperative care to CCUs to ensure favorable postoperative outcomes and cost-effectiveness.
Identifiants
pubmed: 32871742
pii: 34/5/2201
doi: 10.21873/invivo.12030
pmc: PMC7652483
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2201-2208Informations de copyright
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Références
Obstet Gynecol. 1995 Jan;85(1):53-6
pubmed: 7800324
Gynecol Oncol. 2019 Apr;153(1):68-73
pubmed: 30612784
Arch Gynecol Obstet. 2011 Aug;284(2):445-51
pubmed: 20803205
Crit Care. 2011;15(2):217
pubmed: 21457500
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Obstet Gynecol Clin North Am. 2019 Mar;46(1):55-66
pubmed: 30683266
Crit Care Med. 1981 Aug;9(8):591-7
pubmed: 7261642
Cancer. 2009 Mar 15;115(6):1234-44
pubmed: 19189349
Am J Obstet Gynecol. 2019 Jun;220(6):571.e1-571.e8
pubmed: 30771346
Intensive Crit Care Nurs. 2017 Oct;42:122-126
pubmed: 28341399
Gynecol Oncol. 2007 Dec;107(3):464-8
pubmed: 17765297
Gynecol Oncol. 2018 Aug;150(2):306-310
pubmed: 29929924
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Am J Obstet Gynecol. 1997 Jun;176(6):1389-93
pubmed: 9215205
Int J Gynecol Cancer. 2011 Nov;21(8):1336-42
pubmed: 21897266
Gynecol Oncol. 2017 Dec;147(3):612-616
pubmed: 28988028
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1766-9
pubmed: 17009969
Curr Opin Crit Care. 2017 Oct;23(5):424-429
pubmed: 28777159
Int J Gynecol Cancer. 2012 Oct;22(8):1337-43
pubmed: 22964527
Cancer. 2002 Oct 1;95(7):1457-62
pubmed: 12237914
PLoS One. 2017 Oct 23;12(10):e0186725
pubmed: 29059209
Arch Gynecol Obstet. 2014 Aug;290(2):335-9
pubmed: 24639289
Eur J Cancer Care (Engl). 2017 Mar;26(2):
pubmed: 26805516
Surgery. 2018 Apr;163(4):811-818
pubmed: 29433853
Eur J Surg Oncol. 2018 Jun;44(6):750-753
pubmed: 29580734
J Reprod Med. 1997 Mar;42(3):173-8
pubmed: 9109088
Eur Spine J. 2016 Mar;25(3):843-9
pubmed: 26310840
Chin Clin Oncol. 2018 Dec;7(6):57
pubmed: 30180749
Support Care Cancer. 2016 Nov;24(11):4627-32
pubmed: 27306212
Indian J Crit Care Med. 2017 Jan;21(1):17-22
pubmed: 28197046
Curr Opin Crit Care. 2018 Dec;24(6):581-587
pubmed: 30299312
Semin Surg Oncol. 1999 Apr-May;16(3):267-74
pubmed: 10225307